Thrive Global published a study in the journal Diabetes, Obesity and Metabolism showing that persistent users of Lilly’s injectable weight management medication had fewer hospital and emergency room visits and slower healthcare costs over 18 months.

Public source

Publisher name

Public post

One word stands out to me in a remarkable new study from Eli Lilly and Company: persistent. The study, published in "Diabetes, Obesity and Metabolism," followed nearly 1…

Log in to read the full post

Company

About Thrive Global

Founded by Arianna Huffington in 2016, Thrive Global is a leading behavior change technology company with the mission to improve productivity and health outcomes – one Microstep at a time. Thrive helps individuals and organizations improve well-being, performance and mental resilience with its AI-powered behavior change technology platform. Thrive’s Microsteps – small, science-backed steps to improve health and productivity – have been adopted by employees at more than 200 organizations in over 160 countries, from frontline and call center workers to executives at multinational companies. For more information, visit www.thriveglobal.com.

See more

Latest activity

15 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.